Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Conditional knockout of collecting duct bradykinin B2 receptors exacerbates angiotensin II-induced hypertension during high salt intake

L. Kopkan, Z. Husková, Š. Jíchová, L. Červenková, L. Červenka, Z. Saifudeen, SS. El-Dahr,

. 2016 ; 38 (1) : 1-9. [pub] 20150707

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc16028381

Grantová podpora
NT14011 MZ0 CEP - Centrální evidence projektů

We elucidated the role of collecting duct kinin B2 receptor (B2R) in the development of salt-sensitivity and angiotensin II (ANG II)-induced hypertension. To this end, we used a Cre-Lox recombination strategy to generate mice lacking Bdkrb2 gene for B2R in the collecting duct (Hoxb7-Cre(tg/+):Bdkrb2(flox/flox)). In 3 groups of control (Bdkrb2(flox/flox)) and 3 groups of UB(Bdkrb2-/-) mice, systolic blood pressure (SBP) responses to high salt intake (4 or 8% NaCl; HS) were monitored by radiotelemetry in comparison with standard salt diet (0.4% NaCl) prior to and during subcutaneous ANG II infusion (1000 ng/min/kg) via osmotic minipumps. High salt intakes alone for 2 weeks did not alter SBP in either strain. ANG II significantly increased SBP equally in control (121 ± 2 to 156 ± 3 mmHg) and UB(Bdkrb2-/-) mice (120 ± 2 to 153 ± 2 mmHg). The development of ANG II-induced hypertension was exacerbated by 4%HS in both control (125 ± 3 to 164 ± 5 mmHg) and UB(Bdkrb2-/-) mice (124 ± 2 to 162 ± 3 mmHg) during 2 weeks. Interestingly, 8%HS caused a more profound and earlier ANG II-induced hypertension in UB(Bdkrb2-/-) (129 ± 2 to 166 ± 3 mmHg) as compared to control (128 ± 2 to 158 ± 2 mmHg) and it was accompanied by body weight loss and increased mortality. In conclusion, targeted inactivation of B2R in the renal collecting duct does not cause salt-sensitivity; however, collecting duct B2R attenuates the hypertensive actions of ANG II under conditions of very high salt intake.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16028381
003      
CZ-PrNML
005      
20190919141928.0
007      
ta
008      
161005s2016 enk f 000 0|eng||
009      
AR
024    7_
$a 10.3109/10641963.2015.1047945 $2 doi
024    7_
$a 10.3109/10641963.2015.1047945 $2 doi
035    __
$a (PubMed)26151827
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Kopkan, Libor $u Center of Experimental Medicine, Institute for Clinical and Experimental Medicine , Prague , Czech Republic . $7 xx0107287
245    10
$a Conditional knockout of collecting duct bradykinin B2 receptors exacerbates angiotensin II-induced hypertension during high salt intake / $c L. Kopkan, Z. Husková, Š. Jíchová, L. Červenková, L. Červenka, Z. Saifudeen, SS. El-Dahr,
520    9_
$a We elucidated the role of collecting duct kinin B2 receptor (B2R) in the development of salt-sensitivity and angiotensin II (ANG II)-induced hypertension. To this end, we used a Cre-Lox recombination strategy to generate mice lacking Bdkrb2 gene for B2R in the collecting duct (Hoxb7-Cre(tg/+):Bdkrb2(flox/flox)). In 3 groups of control (Bdkrb2(flox/flox)) and 3 groups of UB(Bdkrb2-/-) mice, systolic blood pressure (SBP) responses to high salt intake (4 or 8% NaCl; HS) were monitored by radiotelemetry in comparison with standard salt diet (0.4% NaCl) prior to and during subcutaneous ANG II infusion (1000 ng/min/kg) via osmotic minipumps. High salt intakes alone for 2 weeks did not alter SBP in either strain. ANG II significantly increased SBP equally in control (121 ± 2 to 156 ± 3 mmHg) and UB(Bdkrb2-/-) mice (120 ± 2 to 153 ± 2 mmHg). The development of ANG II-induced hypertension was exacerbated by 4%HS in both control (125 ± 3 to 164 ± 5 mmHg) and UB(Bdkrb2-/-) mice (124 ± 2 to 162 ± 3 mmHg) during 2 weeks. Interestingly, 8%HS caused a more profound and earlier ANG II-induced hypertension in UB(Bdkrb2-/-) (129 ± 2 to 166 ± 3 mmHg) as compared to control (128 ± 2 to 158 ± 2 mmHg) and it was accompanied by body weight loss and increased mortality. In conclusion, targeted inactivation of B2R in the renal collecting duct does not cause salt-sensitivity; however, collecting duct B2R attenuates the hypertensive actions of ANG II under conditions of very high salt intake.
650    _2
$a angiotensin II $x metabolismus $7 D000804
650    _2
$a zvířata $7 D000818
650    12
$a krevní tlak $x účinky léků $x fyziologie $7 D001794
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a genový knockout $7 D055786
650    12
$a hypertenze $x metabolismus $x patofyziologie $7 D006973
650    12
$a sběrací ledvinové kanálky $x metabolismus $x patofyziologie $7 D007685
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a myši $7 D051379
650    _2
$a receptor bradykininu B2 $x genetika $7 D043782
650    _2
$a kuchyňská sůl $x škodlivé účinky $7 D017673
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Husková, Zuzana, $u Center of Experimental Medicine, Institute for Clinical and Experimental Medicine , Prague , Czech Republic . $d 1978- $7 xx0074206
700    1_
$a Jíchová, Šárka. $u Center of Experimental Medicine, Institute for Clinical and Experimental Medicine , Prague , Czech Republic . $7 xx0239935
700    1_
$a Červenková, Lenka $u Center of Experimental Medicine, Institute for Clinical and Experimental Medicine , Prague , Czech Republic . $7 xx0227643
700    1_
$a Červenka, Luděk, $u Center of Experimental Medicine, Institute for Clinical and Experimental Medicine , Prague , Czech Republic . b Department of Pathophysiology, 2nd Faculty of Medicine , Charles University , Prague , Czech Republic , and. $d 1967- $7 xx0037105
700    1_
$a Saifudeen, Zubaida $u Department of Pediatrics , Tulane University School of Medicine , New Orleans , LA , USA.
700    1_
$a El-Dahr, Samir S $u Department of Pediatrics , Tulane University School of Medicine , New Orleans , LA , USA.
773    0_
$w MED00005536 $t Clinical and experimental hypertension (New York, N.Y. 1993) $x 1525-6006 $g Roč. 38, č. 1 (2016), s. 1-9
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26151827 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20161005 $b ABA008
991    __
$a 20190919142319 $b ABA008
999    __
$a ok $b bmc $g 1166695 $s 953011
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 38 $c 1 $d 1-9 $e 20150707 $i 1525-6006 $m Clinical and experimental hypertension $n Clin Exp Hypertens $x MED00005536
GRA    __
$a NT14011 $p MZ0
LZP    __
$a Pubmed-20161005

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...